Guy Johnson
Diagnostic Radiology · Seattle, WANPI 1033300934
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (47.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 83.2% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2024 at $66,935 and has fallen 85.2% since, to $9,897 in 2025. Among diagnostic radiology clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 207 payments — averaging $905.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$156K
- Eisai Inc.$12K
- Biocompatibles, Inc.$11K
- AstraZeneca$3K
- Genentech USA, Inc.$2K
- Astrazeneca UK Limited$2K
- plus $522 from 3 others
Across 8 payments — averaging $11,960 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$96K
What the payments were for
- Consulting fees$73,73839%
- Speaking & faculty fees$89,65448%
- Travel & lodging$16,6949%
- Food & beverage$7,3874%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 178 | $155,955 |
| Eisai Inc. | 8 | $12,266 |
| Biocompatibles, Inc. | 9 | $11,373 |
| AstraZeneca | 4 | $2,861 |
| Genentech USA, Inc. | 4 | $2,348 |
| Astrazeneca UK Limited | 1 | $2,148 |
| Terumo Medical Corporation | 1 | $450 |
| BTG International Canada Inc. | 1 | $44 |
| Argon Medical Devices, Inc. | 1 | $28 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TheraSphere Y90 Glass Microspheres 10 GBq$33,466
- GENERAL EMBOLICS$13,139
- THERASPHERE-BIO$12,383
- LENVIMA$12,116
- GENERAL - THERAPIES$9,789
- TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial)$9,453
- OBSIDIO$8,205
- GENERAL - IO ABLATION$6,375
- GENERAL VASCULAR INTERVENTION$5,836
- IMFINZI$4,163
- GENERAL PAIN MANAGEMENT$2,700
- TECENTRIQ$2,348
- General - Interventional Oncology$1,530
- Azur CX Detachable$450
- THERASPHERE$375
- GENERAL GUIDEWIRES$115
- AXIOS$105
How this compares
$187,473 in reported general payments places this provider in the 95th percentile of 772 diagnostic radiology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other diagnostic radiology in Seattle
- Steve ChenSeattle$281K
- Eniola OluyemiSeattle$147K
- Marissa LawsonSeattle$142K
- Nathan CrossSeattle$141K
- Dushyant SahaniSeattle$84K
- Kathryn LowrySeattle$76K
- Delphine ChenSeattle$60K
- Hubert VesselleSeattle$58K
- Richard HaSeattle$32K
- Manjiri DigheSeattle$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.